Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist.
about
Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.Morphine decreases enteric neuron excitability via inhibition of sodium channels.Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivityBivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats.14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsBinding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mStructure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.Novel cyclic biphalin analogue with improved antinociceptive properties.Interactions between cholecystokinin and opioids in the isolated guinea-pig ileum14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors.
P2860
Q33815047-87DD8E2D-9611-4BB2-8DD4-5A87EBFF9D67Q33893723-D94A3B37-9A14-4B50-8F2E-1ECB5618D2CBQ34428483-70D03955-3611-42B2-9B9F-5F39751CC6DCQ34793128-1BF40C34-A6E6-43A6-AB53-99CD4FD6AD57Q35044112-2EC22B78-8F06-46F5-8D4F-7486DD3BDB6AQ35216655-4DEF0174-4E80-4598-9616-680D2DD24CE4Q35216669-9C982B08-1AB0-4B66-A82E-8AFEC4A27E03Q36015414-3E921BBB-EE5F-4D71-A48E-76ECE4513349Q36186158-C95CE4A2-7130-4361-BB40-68E701CB54AAQ36404602-CFE3DB50-5436-4D80-9188-0AD860DCD629Q37317909-AA0BBE1A-98D4-436D-8B9B-E2B92E0A9CE2Q38373652-50B3C88F-2200-42EC-B7F7-3C7CFE69B7F1Q41838525-46A96E21-90E7-4F33-AF79-448C46F1DC49Q42022883-CC482711-08EE-42F3-82ED-46A55800A587Q42942034-931871E5-EECF-42C5-9977-45A550C5E753Q43117967-7CA0E647-86CC-4D5C-8525-3BA78505546FQ44336937-90722A70-C350-428D-B5DE-F13855F30B4F
P2860
Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist.
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@ast
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@en
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@nl
type
label
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@ast
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@en
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@nl
prefLabel
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@ast
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@en
Synthesis and biological evalu ...... mu opioid receptor antagonist.
@nl
P2093
P356
P1476
Synthesis and biological evalu ...... mu opioid receptor antagonist
@en
P2093
L Eggstein-Aeppli
W P Burkard
P304
P356
10.1021/JM00122A021
P407
P577
1989-02-01T00:00:00Z